Citigroup reissued an outperform rating for DBV Technologies.
5 reports, 2 independent
Updated Sep 16
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reissued an outperform rating for DBV Technologies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
DBV Technologies
publicly owned French biopharmaceutical firm headquartered in Bagneux, France
Related events
- Citigroup reiterated a market outperform rating for KB Home.
- Citigroup upgraded the stock rating for Truist Financial on June 26, 2025.
- Citigroup issued a cautious market rating and price target regarding SMR technology, noting its importance for future business growth.
- Citigroup reissued a positive rating on Cameco shares.
- Citigroup reissued a 'market outperform' rating, noting the growing importance of AI-cloud business over Bitcoin mining.